Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics

References

• Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25. doi:10.1016/j.jacc.2017.04.052
   PubMed Web of Science ®Google Scholar
• Yang W, Zhang A, Han Y, et al. Cyclin-Dependent Kinase Inhibitor 2b Controls Fibrosis and Functional Changes in Ischemia-Induced Heart Failure via the BMI1-p15-Rb Signalling Pathway. Can J Cardiol. 2021;37(4):655–664. doi:10.1016/j.cjca.2020.05.016
   Web of Science ®Google Scholar
• Kelkar AA, Butler J, Schelbert EB, et al. Mechanisms Contributing to the Progression of Ischemic and Nonischemic Dilated Cardiomyopathy. J Am Coll Cardiol. 2015;66(18):2038–2047. doi:10.1016/j.jacc.2015.09.010
   Web of Science ®Google Scholar
• Lubrano V, Balzan S. Role of oxidative stress-related biomarkers in heart failure: galectin 3, alpha1-antitrypsin and LOX-1: new therapeutic perspective? Mol Cell Biochem. 2020;464(1–2):143–152. doi:10.1007/s11010-019-03656-y
   PubMed Web of Science ®Google Scholar
• Mallick A, Januzzi JL. Biomarkers in Acute Heart Failure. Revista Española de Cardiología. 2015;68(6):514–525. doi:10.1016/j.rec.2015.02.009
   PubMed Web of Science ®Google Scholar
• Tromp J, Khan MAF, Mentz RJ, et al. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction. JACC Heart Fail. 2017;5(7):507–517. doi:10.1016/j.jchf.2017.04.007
   PubMed Web of Science ®Google Scholar
• Vegter EL, van der Meer P, de Windt LJ, Pinto YM, Voors AA. MicroRNAs in heart failure: from biomarker to target for therapy. Eur J Heart Fail. 2016;18(5):457–468. doi:10.1002/ejhf.495
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37(27):2129–2200. doi:10.1093/eurheartj/ehw128
   PubMed Web of Science ®Google Scholar
• van der Meer P, Gaggin HK, Dec GW. ACC/AHA Versus ESC Guidelines on Heart Failure. J Am Coll Cardiol. 2019;73(21):2756–2768. doi:10.1016/j.jacc.2019.03.478
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: an Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2016;68(13):1476–1488. doi:10.1016/j.jacc.2016.05.011
   PubMed Web of Science ®Google Scholar
• Wei X-M, Yang W-B, Su -X-X, Zhang A-D, Jin W, Fang Y-H. Plasma free fatty acid is associated with ischemic cardiomyopathy and cardiac dysfunction severity in systolic heart failure patients with diabetes. Chin Med J. 2021;134(4):472–474. doi:10.1097/CM9.0000000000001167
   Web of Science ®Google Scholar
• Huang G, Liu J, Yang C, et al. RNA sequencing discloses the genome wide profile of long noncoding RNAs in dilated cardiomyopathy. Mol Med Rep. 2019;19(4):2569–2580. doi:10.3892/mmr.2019.9937
   Web of Science ®Google Scholar
• Dittenhafer-Reed KE, Richards AL, Fan J, et al. SIRT3 Mediates Multi-Tissue Coupling for Metabolic Fuel Switching. Cell Metab. 2015;21(4):637–646. doi:10.1016/j.cmet.2015.03.007
   Web of Science ®Google Scholar
• Sialana FJ, Wang A-L, Fazari B, et al. Quantitative Proteomics of Synaptosomal Fractions in a Rat Overexpressing Human DISC1 Gene Indicates Profound Synaptic Dysregulation in the Dorsal Striatum. Front Mol Neurosci. 2018;11:26. doi:10.3389/fnmol.2018.00026
   Web of Science ®Google Scholar
• Fu Y, Xu M, Cui Z, et al. Genome-wide identification of FHL1 as a powerful prognostic candidate and potential therapeutic target in acute myeloid leukaemia. EBioMedicine. 2020;52:102664. doi:10.1016/j.ebiom.2020.102664
   PubMed Web of Science ®Google Scholar
• Rangaraju S, Dammer EB, Raza SA, et al. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer s disease. Mol Neurodegener. 2018;13(1):24. doi:10.1186/s13024-018-0254-8
   PubMed Web of Science ®Google Scholar
• Mootha VK, Lindgren CM, Eriksson K-F, et al. PGC-1± -responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267–273. doi:10.1038/ng1180
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc National Acad Sci. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Burger AL, Stojkovic S, Diedrich A, Demyanets S, Wojta J, Pezawas T. Elevated plasma levels of asymmetric dimethylarginine and the risk for arrhythmic death in ischemic and non-ischemic, dilated cardiomyopathy A prospective, controlled long-term study. Clin Biochem. 2020;83:37–42. doi:10.1016/j.clinbiochem.2020.05.016
   Web of Science ®Google Scholar
• Peters S, Kumar S, Elliott P, Kalman JM, Fatkin D. Arrhythmic Genotypes in Familial Dilated Cardiomyopathy: implications for Genetic Testing and Clinical Management. Heart Lung Circ. 2019;28(1):31–38. doi:10.1016/j.hlc.2018.09.010
   Web of Science ®Google Scholar
• Rady M, Ulbrich S, Heidrich F, et al. Left Ventricular Torsion A New Echocardiographic Prognosticator in Patients With Non-Ischemic Dilated Cardiomyopathy. Cir J. 2019;83(3):595–603. doi:10.1253/circj.CJ-18-0986
   Google Scholar
• Ponomareva OY, Holmen IC, Sperry AJ, Eliceiri KW, Halloran MC. Calsyntenin-1 Regulates Axon Branching and Endosomal Trafficking during Sensory Neuron Development In Vivo. J Neurosci. 2014;34(28):9235–9248. doi:10.1523/JNEUROSCI.0561-14.2014
   Web of Science ®Google Scholar
• Vagnoni A, Perkinton MS, Gray EH, Francis PT, Noble W, Miller CCJ. Calsyntenin-1 mediates axonal transport of the amyloid precursor protein and regulates A production. Hum Mol Genet. 2012;21(13):2845–2854. doi:10.1093/hmg/dds109
   Web of Science ®Google Scholar
• Vogt L, Schrimpf SP, Meskenaite V, et al. Calsyntenin-1, a Proteolytically Processed Postsynaptic Membrane Protein with a Cytoplasmic Calcium-Binding Domain. Mol Cell Neurosci. 2001;17(1):151–166. doi:10.1006/mcne.2000.0937
   Web of Science ®Google Scholar
• Yang M, Yu M, Guan D, et al. ASK1-JNK signaling cascade mediates Ad-ST13-induced apoptosis in colorectal HCT116 cells. J Cell Biochem. 2010;110(3):581–588. doi:10.1002/jcb.22551
   Web of Science ®Google Scholar
• Yang M, Cao X, Yu MC, et al. Potent Antitumor Efficacy of ST13 for Colorectal Cancer Mediated by Oncolytic Adenovirus via Mitochondrial Apoptotic Cell Death. Hum Gene Ther. 2008;19(4):343–353. doi:10.1089/hum.2007.0137
   PubMed Web of Science ®Google Scholar
• Yang W, Wei X, Su X, Shen Y, Jin W, Fang Y. Depletion of beta3-adrenergic receptor induces left ventricular diastolic dysfunction via potential regulation of energy metabolism and cardiac contraction. Gene. 2019;697:1–10. doi:10.1016/j.gene.2019.02.038
   Web of Science ®Google Scholar
• Arnett DK, Meyers KJ, Devereux RB, et al. Genetic Variation in NCAM1 Contributes to Left Ventricular Wall Thickness in Hypertensive Families. Circ Res. 2011;108(3):279–283. doi:10.1161/CIRCRESAHA.110.239210
   PubMed Web of Science ®Google Scholar
• Barac YD, Emrich F, Krutzwakd-Josefson E, et al. The ubiquitin-proteasome system: a potential therapeutic target for heart failure. J Heart Lung Transplantation. 2017;36(7):708–714. doi:10.1016/j.healun.2017.02.012
   Web of Science ®Google Scholar
• Liu J, Su H, Wang X. The COP9 signalosome coerces autophagy and the ubiquitin-proteasome system to police the heart. Autophagy. 2016;12(3):601–602. doi:10.1080/15548627.2015.1136773
   PubMed Web of Science ®Google Scholar
• Pagan J, Seto T, Pagano M, Cittadini A. Role of the Ubiquitin Proteasome System in the Heart. Circ Res. 2013;112(7):1046–1058. doi:10.1161/CIRCRESAHA.112.300521
   Web of Science ®Google Scholar
• Milting H, Ellinghaus P, Seewald M, et al. Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices. J Heart Lung Transplant. 2008;27(6):589–596. doi:10.1016/j.healun.2008.02.018
   PubMed Web of Science ®Google Scholar
• Chan MY, Efthymios M, Tan SH, et al. Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics. Circulation. 2020;142(15):1408–1421. doi:10.1161/CIRCULATIONAHA.119.045158
   PubMed Web of Science ®Google Scholar
• Liu Z, Xu Q, Yang Q, et al. Vascular peroxidase 1 is a novel regulator of cardiac fibrosis after myocardial infarction. Redox Biol. 2019;22:101151. doi:10.1016/j.redox.2019.101151
   Web of Science ®Google Scholar
• Shang J, Gao Z-Y, Zhang L-Y, Wang C-Y. Over-expression of JAZF1 promotes cardiac microvascular endothelial cell proliferation and angiogenesis via activation of the Akt signaling pathway in rats with myocardial ischemia-reperfusion. Cell Cycle. 2019;18(14):1619–1634. doi:10.1080/15384101.2019.1629774
   PubMed Web of Science ®Google Scholar
• Du G-Q, Shao Z-B, Wu J, et al. Targeted myocardial delivery of GDF11 gene rejuvenates the aged mouse heart and enhances myocardial regeneration after ischemia reperfusion injury. Basic Res Cardiol. 2017;112(1):7. doi:10.1007/s00395-016-0593-y
   PubMed Web of Science ®Google Scholar
• Beadle RM, Williams LK, Kuehl M, et al. Improvement in Cardiac Energetics by Perhexiline in Heart Failure Due to Dilated Cardiomyopathy. JACC Heart Fail. 2015;3(3):202–211. doi:10.1016/j.jchf.2014.09.009
   Web of Science ®Google Scholar
• Tuunanen H, Engblom E, Naum A, et al. Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy. Circulation. 2008;118(12):1250–1258. doi:10.1161/CIRCULATIONAHA.108.778019
   PubMed Web of Science ®Google Scholar